00:18:42 Europe / Stockholm
Svenska | English

Modulight

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-10-18 15-10 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-06 Ordinarie utdelning MODU 0.00 EUR
2024-04-26 15-10 2024-Q1
2024-02-23 Bokslutskommuniké 2023
2023-10-20 15-10 2023-Q3
2023-08-18 Kvartalsrapport 2023-Q2
2023-05-03 Ordinarie utdelning MODU 0.00 EUR
2023-05-02 Årsstämma 2024
2023-04-28 15-10 2023-Q1
2023-02-23 Bokslutskommuniké 2022
2022-08-19 Kvartalsrapport 2022-Q2
2022-05-03 Ordinarie utdelning MODU 0.00 EUR
2022-05-02 Årsstämma 2022

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.
Modulight to publish its business review for January–September 2023 on October 20, 2023
2023-10-13 08:55:00

Modulight Corporation | Press Release | October 13, 2023 at 09:55:00 EEST

Modulight Corporation will publish its business review for January–September 2023 on Friday, October 20, 2023, at 1:00 p.m. EEST.
 
Modulight's CEO Seppo Orsila will present the result in an English-language webcast, which will be held on October 20, 2023, at 2:30 p.m. EEST. The broadcast can be followed at modulight.videosync.fi/q3-2023-results. Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions. Presentation materials will be available before the start of the event on the company’s website at modulight.com/reports-presentations/.

Contacts

CEO Seppo Orsila m. +358 40 830 4671
CFO Anca Guina m. +358 40 830 4674
IR Ulla Haapanen m. +358 40 830 4676
Email: ir@modulight.com

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | Twitter | LinkedIn | Facebook | YouTube | Instagram | #killcancer #laserfamily

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden